Compare PRGO & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRGO | SGRY |
|---|---|---|
| Founded | 1887 | 2004 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2013 | 2015 |
| Metric | PRGO | SGRY |
|---|---|---|
| Price | $10.78 | $13.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $19.33 | ★ $23.44 |
| AVG Volume (30 Days) | ★ 2.8M | 2.0M |
| Earning Date | 05-29-2026 | 05-26-2026 |
| Dividend Yield | ★ 10.36% | N/A |
| EPS Growth | N/A | ★ 54.14 |
| EPS | N/A | ★ N/A |
| Revenue | $800,000.00 | ★ $1,145,438,000.00 |
| Revenue This Year | $0.02 | $9.71 |
| Revenue Next Year | $1.36 | $7.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.13 | $12.25 |
| 52 Week High | $29.08 | $24.60 |
| Indicator | PRGO | SGRY |
|---|---|---|
| Relative Strength Index (RSI) | 22.11 | 35.06 |
| Support Level | N/A | $13.14 |
| Resistance Level | $15.08 | $16.28 |
| Average True Range (ATR) | 0.60 | 0.67 |
| MACD | -0.41 | -0.18 |
| Stochastic Oscillator | 2.84 | 30.11 |
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.